Information for healthcare professionals and parents on the increased risk of fever when the MenB vaccine is given alongside other immunisations at 2 and 4 months of age and the recommended use of prophylactic paracetamol.
Using paracetamol to prevent and treat fever after MenB vaccination
The advice on the use of paracetamol following MenB vaccination differs to previous advice on the use of paracetamol for post-vaccination fever which may still appear on infant paracetamol product packaging. In order to avoid confusion, a patient information leaflet has been produced detailing advice on paracetamol dosage and timings and addressing frequently asked questions.
Paper copies of
the leaflet are free to order
and every parent or guardian should be given a copy at the 2 month
MenB and paracetamol mock consultation
The UK Health Security Agency (UKHSA) has been working closely with Oxford Vaccine Group who have produced a mock video consultation including a discussion between a practice nurse and patient about the use of paracetamol following MenB vaccination. This is a key training resource for frontline immunisers to ensure that parents receive the necessary information on the increased risk of fever and correct use of paracetamol following the 2 and 4 month appointment visits. Local NHS England and UKHSA colleagues are requested to help to cascade this training locally to frontline immunisers.
MenB and Paracetamol consultation